Parent Drug Name | Name of Impurity | Catalogue No. | |
---|---|---|---|
Aceclofenac | Aceclofenac EP Impurity A | VL284007 | View CAS 15307-86-5 |
Aceclofenac | Aceclofenac EP Impurity A (Sodium Salt) | VE006620 | View CAS 15307-79-6 |
Aceclofenac | Aceclofenac EP Impurity B | VL284005 | View CAS 15307-78-5 |
Aceclofenac | Aceclofenac EP Impurity C | VL284006 | View CAS 15307-77-4 |
Aceclofenac | Aceclofenac EP Impurity D | VL284002 | View CAS 139272-66-5 |
Aceclofenac | Aceclofenac EP Impurity E | VL284003 | View CAS 139272-67-6 |
Aceclofenac | Aceclofenac EP Impurity F | VL284001 | View CAS 100499-89-6 |
Aceclofenac | Aceclofenac EP Impurity G | VL284009 | View CAS 1215709-75-3 |
Aceclofenac | Aceclofenac EP Impurity H | VL284008 | View CAS 1216495-92-9 |
Aceclofenac | Aceclofenac Impurity 2 | VE0011684 | View |
Aceclofenac | Aceclofenac Impurity 4 | VE0011685 | View |
Aceclofenac | Aceclofenac Impurity 5 | VE0011686 | View |
Aceclofenac | Aceclofenac Tert Butyl Ester | VL284010 | View CAS 139272-68-7 |
Aceclofenac | Aceclofenac-D4 | DVE00108 | View |
Aceclofenac | Aceclofenac-D7 | DVE00107 | View |
Aceclofenac | 4'-Hydroxy Aceclofenac | VL284012 | View CAS 229308-90-1 |
Aceclofenac Related Compound
It is used to treat rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis pain and inflammation.
References
- Shailendra Singh Solanki, and Rashmi Dahima. Formulation and Evaluation of Aceclofenac Mouth-Dissolving Tablet. Apr. 2011, https://doi.org/10.4103/2231-4040.82951. Accessed 6 June 2023.
- “Aceclofenac: Uses, Interactions, Mechanism of Action | DrugBank Online.” Drugbank.com, DrugBank, 2014, go.drugbank.com/drugs/DB06736. Accessed 6 June 2023.
FAQ
Does aceclofenac block COX-2?
Aceclofenac is preferable to other NSAIDs because it possesses selectivity for Cox-2, a useful Cox inhibitor, is well tolerated, and has improved GI tolerance.
Aceclofenac is preferable to other NSAIDs because it possesses selectivity for Cox-2, a useful Cox inhibitor, is well tolerated, and has improved GI tolerance.
Aceclofenac is preferable to other NSAIDs because it possesses selectivity for Cox-2, a useful Cox inhibitor, is well tolerated, and has improved GI tolerance.